CD226 and cancer: However, this metastasis-suppressive effect by inhibiting DNAM-1 only happens within three days of melanoma injections into mice, whereas, later, this inhibition is not observed, suggesting the DNAM-1-mediated NK cell activation to only be effective during early cancer growth stages [191].